Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 8 of 8  Show

Literature citations Results

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.

Oliveira S.A., Scott W.K., Martin E.R., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C. et al.

Ann. Neurol. 53:624-629(2003) · UniProtKB (1)

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

PD GWAS Consortium
Pankratz N., Beecham G.W., DeStefano A.L., Dawson T.M., Doheny K.F., Factor S.A., Hamza T.H., Hung A.Y., Hyman B.T., Ivinson A.J. et al.

Ann. Neurol. 71:370-384(2012) · Mapped (1)

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.

Li Y.J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., Hauser M.A., Scott W.K., Small G.W., Nance M.A. et al.

Hum. Mol. Genet. 12:3259-3267(2003) · Mapped (6)

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

van der Walt J.M., Martin E.R., Scott W.K., Zhang F., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K. et al.

Neurology 60:1189-1191(2003) · Mapped (47)

Genetic influences on cognitive decline in Parkinson's disease.

Morley J.F., Xie S.X., Hurtig H.I., Stern M.B., Colcher A., Horn S., Dahodwala N., Duda J.E., Weintraub D., Chen-Plotkin A.S. et al.

Mov. Disord. 27:512-518(2012) · Mapped (24)

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy.

Ozelius L.J., Foroud T., May S., Senthil G., Sandroni P., Low P.A., Reich S., Colcher A., Stern M.B., Ondo W.G. et al.

Mov. Disord. 22:546-549(2007) · Mapped (5)

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.

Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A. et al.

JAMA 286:2245-2250(2001) · Mapped (11)

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Li Y.J., Hauser M.A., Scott W.K., Martin E.R., Booze M.W., Qin X.J., Walter J.W., Nance M.A., Hubble J.P., Koller W.C. et al.

Neurology 62:2005-2009(2004) · Mapped (12)

1 to 8 of 8  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again